Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Interviews as Topic × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 17 Prostatic Neoplasms 15 Neoplasms 14 Colorectal Neoplasms 13 Hematopoietic and Lymphatic System Neoplasm 9 Hematologic Neoplasms 8 Lung Neoplasms 7 Ovarian Neoplasms 4 Multiple Myeloma 4 Malignant Solid Neoplasm 4 Lymphoma 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Endometrial Neoplasms 3 Advanced Malignant Solid Neoplasm 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity-Related Malignant Neoplasm 2 Mouth Neoplasms 2 Motor Activity 2 Leukemia 2 Head and Neck Carcinoma 2 Genital Neoplasms, Female 2 Genetic Predisposition to Disease 2 Depression 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Behavior 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1

Interventions

pembrolizumab 49 Cisplatin 38 Radiotherapy 24 Cetuximab 22 Carboplatin 20 Nivolumab 15 Paclitaxel 14 Docetaxel 14 Surveys and Questionnaires 11 Fluorouracil 11 Drug Therapy 10 Blood Specimen Collection 10 Radiotherapy, Intensity-Modulated 8 tislelizumab 7 atezolizumab 6 Radiation 6 Standard of Care 5 Afatinib 5 cemiplimab 4 Chemoradiotherapy 4 toripalimab 3 palbociclib 3 dostarlimab 3 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Fulvestrant 3 Erlotinib Hydrochloride 3 Equipment and Supplies 3 Capecitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡